Physician profile
Thomas A Botta
NPI 1417177072
$258.77
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.50 · 2020: $11.26 · 2022: $20.75 · 2023: $137 · 2024: $20.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $95.27 · Education: $62.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $95.27 |
| Education | $62.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $62.99 | 2023 | |
| Glaxosmithkline, LLC. | $41.67 | 2023 | Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $24.20 | 2019-2020 | |
| Neurelis, INC. | $20.92 | 2024 | Valtoco |
| Pfizer INC. | $20.75 | 2022 | |
| Celgene Corporation | $19.55 | 2019 | |
| Genzyme Corporation | $19.31 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $18.22 | 2019 | |
| Seagen INC. | $17.79 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.37 | 2023 | Xarelto |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Botta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.